The global Dental Membrane And Bone Graft Substitute Market is estimated to be valued at US$ 1,045.3 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Dental membranes and bone graft substitutes are used in dental and oral applications to treat conditions like dental defects, bone fractures and bone regeneration. They act as scaffolds for new bone formation and promote tissue healing.
Market key trends:
One of the key trends in the dental membrane and bone graft substitute market is the increasing use of bone morphogenetic proteins (BMP) for dental bone grafts. BMPs are growth factors that help induce local cells to develop into bone-forming cells. They have been found to significantly enhance new bone formation compared to traditional bone grafting alone. Research is also ongoing to develop advanced bone graft substitutes composed of synthetic biomaterials that can mimic natural bone and promote more rapid regeneration.
SWOT Analysis
Strength: The market offers wide range of dental membrane and bone graft substitutes for different dental procedures like socket preservation, ridge augmentation, sinus lift procedure and alveolar reconstruction etc. These products aid in faster healing and reduce chances of infections.
Weakness: High cost of advanced dental membrane and bone graft products limits their widespread adoption. Lack of awareness among population in developing nations regarding dental implantation procedures.
Opportunity: Rising geriatric population susceptible to tooth loss and increasing dental tourism are driving the demand. Favorable reimbursement policies for dental implantation are encouraging people to undergo such procedures.
Threats: Stringent regulatory frameworks and lengthy approval process increases the entry barriers. Uncertain reimbursement scenario in some countries negatively impact the market.
Key Takeaways
The global dental membrane and bone graft substitute market is expected to witness high growth, exhibiting CAGR of 9.4% over the forecast period, due to increasing number of tooth extraction and dental implantation procedures.
Regional analysis:
North America dominated the market and is expected to remain the largest market during the forecast period owing to growing geriatric population, availability of advanced healthcare infrastructure and favorable reimbursement policies. Asia Pacific is expected to exhibit the fastest growth rate over the coming years driven by growing medical tourism industry and increasing disposable income.
Key players operating in the Dental Membrane And Bone Graft Substitute Market are Zimmer Biomet, Geistlich Pharma North America Inc., ACE Surgical Supply Company, Inc., BioHorizons, LifeNet Health, RTI Surgical, Institut Straumann AG, Dentsply Sirona Inc., Citagenix, Inc., Orthogen AG, DentiumUSA, KaVo Dental, Danaher, BONESUPPORT AB, Cerapedics, Inc., Molecular Matrix, Inc., Medtronic, LASAK s.r.o., Collagen Matrix, Inc., and OrthoPediatrics Corp.
